KREATECH Diagnostics

📍 Amsterdam, Netherlands👥 7 employees💰 Last funded 2005
Biotechnology🌐 kreatech.com
Website LinkedIn
KREATECH Diagnostics is a Molecular Diagnostics company focusing on the development and world-wide commercialization of innovative detection products. KREATECH’s product portfolio enables customers to detect genetic aberrations that may lead to cancer or other diseases. KREATECH offers the broadest commercial portfolio of DNA-FISH probes available in the industry: more than 450 REPEAT-FREE™ POSEIDON™ FISH probes. The REPEAT-FREE™ technology eliminates the use of Cot-1 or blocking DNA, providing less background and a brighter signal which are important features for FISH as a diagnostic and research tool. In addition, KREATECH has a portfolio for dedicated (microarray) labeling applications using its proprietary non-enzymatic Universal Linkage System (ULS™) labeling technology. KREATECH Diagnostics has commercial operations both in Europe and North America. For more information, please visit www.kreatech.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in KREATECH Diagnostics?
KREATECH Diagnostics has 1 investors on record on gritt.io.
When did KREATECH Diagnostics last raise funding?
The most recent investment in KREATECH Diagnostics recorded on gritt.io was in 2005.
What industry is KREATECH Diagnostics in?
KREATECH Diagnostics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is KREATECH Diagnostics based?
KREATECH Diagnostics is headquartered in Amsterdam, Netherlands.